Nighttime BP, Circadian Rhythm of BP May Affect Cardiovascular Risk

TUESDAY, Nov. 3, 2020 -- Elevated nighttime systolic blood pressure (BP) and a disrupted circadian pattern for BP are associated with an increased risk for certain cardiovascular events, such as heart failure, according to a study published online Nov. 2 in Circulation.

Kazuomi Kario, M.D., Ph.D., from the Jichi Medical University School of Medicine in Shimotsuke, Japan, and colleagues conducted a nationwide prospective, observational study involving 6,359 patients with at least one cardiovascular risk factor and free of symptomatic cardiovascular disease at baseline. Patients were followed annually for primary cardiovascular end points (atherosclerotic cardiovascular disease and heart failure).

The researchers identified 306 cardiovascular events during a mean follow-up of 4.5 ± 2.4 years. After adjustment for demographic and clinical risk factors, there was a significant association seen for nighttime systolic BP with the risk for atherosclerotic cardiovascular disease and heart failure (hazard ratios per 20-mm Hg increase, 1.18 [95 percent confidence interval (CI), 1.02 to 1.37; P = 0.029] and 1.25 [95 percent CI, 1.00 to 1.55; P = 0.048], respectively). Compared with normal circadian rhythm, there was a significant association noted for disrupted circadian BP rhythm (riser pattern, nighttime BP higher than daytime BP) with higher overall cardiovascular disease risk and heart failure (hazard ratios, 1.48 [95 percent CI, 1.05 to 2.08; P = 0.024] and 2.45 [95 percent CI, 1.34 to 4.48; P = 0.004], respectively).

"Results indicate that nighttime systolic blood pressure was a significant, independent risk factor for cardiovascular events," Kario said in a statement. "The study highlights the importance of including nighttime blood pressure monitoring in patient management strategies and will hopefully encourage physicians to ensure that antihypertensive therapy is effectively lowering blood pressure throughout the 24-hour dosing period."

One author disclosed financial ties to the medical device industry.

Abstract/Full Text

© 2020 HealthDay. All rights reserved.

Posted: November 2020

Read this next

Diets High in Inflammatory Potential Linked to Cardiovascular Disease

TUESDAY, Nov. 3, 2020 -- Dietary patterns with higher inflammatory potential are associated with an increased risk for cardiovascular disease (CVD), coronary heart disease (CHD),...

Masked Asleep Hypertension Common in U.S. Adults

MONDAY, Nov. 2, 2020 -- The prevalence of masked asleep hypertension is high among U.S. adults, according to a study published online Oct. 28 in JAMA Cardiology. Siling Li, from...

Lipid Screen, CVD Assessment Advised in Endocrine Disorders

FRIDAY, Oct. 30, 2020 -- Lipid screening and cardiovascular risk assessment should be performed for all patients with endocrine disorders, according to an Endocrine Society...

More News Resources

Subscribe to our Newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.